Bridgewater Associates’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BBA
Bridgewater Associates's RYTM Position: Q3 2026 in Review
Bridgewater Associates opened a new position in Rhythm Pharmaceuticals (RYTM) in Q3 2026: 95,074 shares worth $9.05M. The stake represents 0.04% of the portfolio and ranks #420 among its holdings.
333 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- Bridgewater Associates held 95,074 shares of Rhythm Pharmaceuticals worth $9.05M as of Q3 2026.
- Rhythm Pharmaceuticals was a new Bridgewater Associates position in Q3 2026.
- Rhythm Pharmaceuticals made up 0.04% of Bridgewater Associates's portfolio in Q3 2026, its #420 holding.
- 333 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on Bridgewater Associates's 13F filing for Q3 2026, filed 16 Nov 2026.